This AMACR monoclonal antibody is produced using hybridoma technology. Mice are immunized with a recombinant peptide derived from human AMACR protein. B cells from immunized mice are fused with myeloma cells to generate hybridomas. Hybridomas producing the AMACR antibody are selected and cultured. The antibody is purified from mouse ascites fluid via affinity chromatography using the specific immunogen. This unconjugated IgG1, Kappa isotype antibody is suitable for detecting human AMACR protein in ELISA and immunohistochemistry (IHC) assays.
AMACR (alpha-methylacyl-CoA racemase) is an enzyme crucial in the beta-oxidation of branched-chain fatty acids and the metabolism of certain drugs and xenobiotics. Its function is to catalyze the racemization of alpha-methyl branched-chain fatty acid coenzyme A (CoA) esters, converting the 2R-isomers to the 2S-isomers. Elevated AMACR expression is observed in various cancers, notably prostate cancer, making it a valuable diagnostic marker.
Monoclonal antibodies (mAbs) are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system’s attack on cells . They are produced by identical immune cells that are all clones of a unique parent cell . Monoclonal antibodies can be classified based on their source and structure:
Monoclonal antibodies exhibit several key biological properties:
Monoclonal antibodies play crucial roles in the immune system:
Monoclonal antibodies interact with other molecules and cells through various mechanisms:
The expression and activity of monoclonal antibodies are tightly regulated:
Monoclonal antibodies have a wide range of applications in biomedical research and medicine: